Inari Medical (NASDAQ:NARI) Earns Hold Rating from Analysts at Stifel Nicolaus
Stifel Nicolaus initiated coverage on shares of Inari Medical (NASDAQ:NARI – Free Report) in a research report released on Tuesday morning, Marketbeat.com reports. The firm issued a hold rating and a $50.00 price target on the stock. Several other equities analysts have also recently commented on NARI. Piper Sandler reiterated a neutral rating and set […]
More Stories
More Than 100 Cases of Norovirus Reported on Cruise Ship: CDC
By Jack Phillips A norovirus outbreak has sickened more than 100 people on an Aida Cruises ship, according to an...
Student Sues North Carolina School District After Tribute to Charlie Kirk Is Censored
By Tom Ozimek A North Carolina high school student and her parents have sued the Charlotte-Mecklenburg Board of Education, alleging...
Trump Warns ‘Biggest Threat’ to US Would Be Supreme Court Overruling Tariffs
By Jack Phillips President Donald Trump on Tuesday said that national security could be at risk if the Supreme Court...
Federal Reserve Poised to Cut Interest Rates at Final Meeting of 2025
By Andrew Moran The Federal Reserve’s final policy meeting of the year is expected to end with an interest rate...
Will Japanese Series, The Fragrant Flower Blooms With Dignity, Return for Season 2?
The Japanese animated drama, The Fragrant Flower Blooms With Dignity, is getting praised by many viewers from around the world....
6 Best Analytics Agencies in 2026 to Level Up Your Data Strategy
What do businesses do? Build and innovate from raw and scratch, right? But creation generates its own new raw material,...